Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (12 ops.)
Latest filing published 27 Apr 2026 for Amicus Therapeutics, INC., €1.8M. Read the official filing
Filing timeline
BuySaleSimon N.R. Harford
Insider track record
Disclosed buys
0
Disclosed sells
12
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Simon N.R. Harford: trading record in brief
Simon N.R. Harford is a declared insider at 2 companies (finance chief); the most frequent names are Albireo Pharma, Inc. and Amicus Therapeutics, Inc. The record holds 23 filings, for trades running from 13 July 2021 to 27 April 2026.
The open-market record consists of 12 sales worth €108k, with no purchase. Outside the open market, there are 9 share grants.
The latest filing, published on 27 April 2026, reports a transaction of €1.8M in Amicus Therapeutics, Inc. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Simon N.R. Harford
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations23 total
143,595 shares@ US$14.500.045% mcap62.5% of flowCommon StockSEC:0001193125-26-182244:0
71,303 shares@ US$14.2580.9% of flowCommon StockSEC:0001193125-25-337337:0
12,529 shares@ US$7.602.8% of flowCommon StockSEC:0001443705-25-000004:0
7,482 shares@ US$9.316.3% of flowCommon StockSEC:0000950170-25-002421:0
12,529 shares@ US$12.0912.7% of flowCommon StockSEC:0000950170-24-100253:0
57,392 shares0Common StockSEC:0000950170-24-002094:0
106,973 shares0Common StockSEC:0001209191-23-047104:0
13,739 sharesCommon StockSEC:0001209191-23-014786:0
55,000 shares0Common StockSEC:0001209191-23-005333:0
55,000 shares0Common StockSEC:0001209191-23-004948:0
102 shares@ US$43.803.3% of flowCommon StockSEC:0001209191-23-004453:0
1,776 shares@ US$43.8057.5% of flowCommon StockSEC:0001209191-23-004219:0
104 shares@ US$19.57641.6% of flowCommon StockSEC:0001209191-22-054487:0
80 shares@ US$23.78581.6% of flowCommon StockSEC:0001209191-22-053556:0
106 shares@ US$24.67132.0% of flowCommon StockSEC:0001209191-22-043106:0
95 shares@ US$24.02761.8% of flowCommon StockSEC:0001209191-22-042038:0
103 shares@ US$32.92472.9% of flowCommon StockSEC:0001209191-22-025525:0
96 shares@ US$35.74392.9% of flowCommon StockSEC:0001209191-22-023974:0
416 shares@ US$24.88228.4% of flowCommon StockSEC:0001209191-22-004807:0
21,600 shares0Common StockSEC:0001209191-22-004063:0
111 shares@ US$25.94642.3% of flowCommon StockSEC:0001209191-22-002923:0
93 shares@ US$30.23392.2% of flowCommon StockSEC:0001209191-21-060216:0
98 shares@ US$35.022.7% of flowCommon StockSEC:0001209191-21-046787:0
23 of 23 declarations
